Arduous and lengthy treatment of tuberculosis

Papua New Guinea

We are working to improve access to screening and treatment for tuberculosis (TB) in Papua New Guinea.

In collaboration with the national TB programme, our team has been scaling up the capacities for screening, diagnosis, treatment initiation and follow-up in Port Moresby’s Gerehu hospital. Mobile teams work in the community to improve patient adherence to treatment.

In Gulf province, our TB programme supports two health centres as well as Kerema general hospital.

In 2020, MSF teams responded to the COVID-19 pandemic, treating patients in Port Moresby and training medical staff in 22 provinces.

Our activities in 2020 in Papua New Guinea

Data and information from the International Activity Report 2020.

MSF in Papua New Guinea in 2020 In Papua New Guinea, MSF continued to treat patients with tuberculosis (TB), the second-highest cause of death in the country. We also supported the national COVID-19 response.
PNG Activities 2020

Our teams collaborate with the national TB programme to improve screening, prevention, diagnosis, treatment initiation and follow-up at Gerehu hospital in the capital, Port Moresby, and in Kerema in Gulf province.

MSF follows the World Health Organization’s new treatment recommendations for multidrug-resistant TB (MDR-TB), which means that all medication is oral and patients no longer need to have painful daily injections. This, and the reduction in severe side effects, leads to better treatment adherence.

In Port Moresby, we provide care to patients with drug-sensitive and drug-resistant forms of TB, including home visits when required. In 2020, many patients came from outside our clinic’s catchment area to seek care. We referred those who were diagnosed with TB to different treatment facilities for registration and treatment. We also built a TB laboratory at Tokarara clinic to support the National Capital District provincial health authority in expanding diagnosis in the North West catchment area.   

Kerema is a largely rural district, with isolated communities spread over a wide area and limited access to healthcare. Although we saw fewer TB patients compared to previous years, we continued to offer diagnosis and care to patients in the catchment areas of two general healthcare facilities, Kerema and Malalawa. We strengthened patient follow-up, which resulted in fewer patients stopping treatment prematurely. In Kerema public hospital, we supported TB laboratory activities and integrated HIV screening.

The country saw a relatively small number of COVID-19 infections throughout 2020. Our teams conducted training in infection prevention and control, and provided technical assistance to the Department of Health for the construction of a dedicated COVID-19 treatment facility in Port Moresby. We also supported the laboratory of that makeshift hospital by implementing rapid COVID-19 testing, reducing the turnaround time to less than one hour. The implementation of a well-coordinated find, test, trace, isolate and support system aimed to identify and end outbreaks before they became unmanageable.

 

in 2020
 
Arduous and lengthy treatment of tuberculosis
Coronavirus COVID-19 pandemic

Three questions on worrying COVID-19 surge in Papua New Guinea

Interview 25 Mar 2021
 
Training session for COVID-19 in Cambodia
Coronavirus COVID-19 pandemic

Preparing for COVID-19 in South-East Asia

Interview 5 Mar 2020
 
Arduous and lengthy treatment of tuberculosis
Tuberculosis

Patients tackle arduous and lengthy tuberculosis treatment in Papua New Guinea

Project Update 30 Oct 2019
 
TB programs in Gulf Province and Port Moresby
Papua New Guinea

Bringing TB treatment closer to home

Project Update 23 Mar 2018
 
Papua New Guinea

MSF urges access to asylum seekers and refugees in Manus Island Transit Centres

Statement 25 Nov 2017
 
"RETURN TO ABUSER" - Family and Sexual Violence Papua New Guinea
Photo Story

Cycles of abuse and gender based violence revealed in Papua New Guinea

1 Mar 2016
Photo Story